ArticleLung India : official organ of Indian Chest Society2026
Treatment of bronchial asthma - A simplified overview.
Article in Lung India : official organ of Indian Chest Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractThe treatment of bronchial asthma is complex and includes both pharmacological and non-pharmacological approaches. The main goals of therapy are to achieve and maintain disease control, minimize symptoms, prevent exacerbations, and improve the patient's quality of life. Inhaled corticosteroids (ICSs), bronchodilators, and biological therapy play a key role in severe forms of asthma. Patient education, identification and elimination of triggers of asthma attacks, and regular monitoring of the condition are also an integral part of disease management. Research in asthma management points to new therapeutic options that are tailored precisely to the endotype of the disease and the phenotype of the patient. Early diagnosis and individually tailored treatment are key factors to achieve remission and improve the prognosis of patients with bronchial asthma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.